Motilal Oswal's research report on Deepak Nitrite
Deepak Nitrite (DN) reported a miss on our estimate. EBITDA came in 9% lower than our estimate at INR2.7b, while EBITDA margin – at 13.8% – was also below our estimate of 16.3%, the lowest since 1QFY19. The miss was largely due to the Phenolic segment. EBIT margin contracted to 8% in Deepak Phenolics, the lowest since 4QFY20. Management announced that it has commissioned a project (for an agrochemical product) in Oct’22 for which the entire volumes are tied up for the next five years – it expects another project to be commissioned in Nov’22, which would be margin accretive.
Outlook
The stock trades at 24x/23x FY23E/FY24E EPS. With pricing environment remaining volatile and limited earnings growth opportunities until the time Greenfield expansions get commissioned (phenol downstream products would result in captive phenol consumption of 35-40%), we maintain our Neutral rating. We value the stock at 22x FY24E EPS, to arrive at our TP of INR1,890.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.